NPI: 1659334431 · MICHIGAN CITY, IN 46360 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/11/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (SR DIRECTOR LICENSURE&CERTIFICATION) |
| NPI Enumeration Date | 04/11/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 29,462 | $57K |
| 2019 | 22,743 | $51K |
| 2020 | 29,653 | $108K |
| 2021 | 32,634 | $107K |
| 2022 | 21,557 | $149K |
| 2023 | 7,408 | $243K |
| 2024 | 2,656 | $197K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 49,656 | 2,570 | $841K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 43,033 | 1,530 | $40K |
| J1756 | Injection, iron sucrose, 1 mg | 9,343 | 1,492 | $15K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 414 | 160 | $15K |
| J1270 | Injection, doxercalciferol, 1 mcg | 25,948 | 1,353 | $2K |
| 83970 | 2,260 | 1,278 | $119.24 | |
| 85045 | 2,398 | 1,384 | $76.31 | |
| 85041 | 2,423 | 1,407 | $69.46 | |
| 85048 | 2,412 | 1,404 | $68.65 | |
| 83540 | 1,446 | 825 | $21.87 | |
| 82728 | 1,083 | 650 | $21.16 | |
| A4657 | Syringe, with or without needle, each | 3,488 | 1,704 | $20.09 |
| 83550 | 1,030 | 621 | $17.44 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 792 | 332 | $5.37 |
| 0012A | 36 | 16 | $4.03 | |
| 0011A | 52 | 17 | $4.03 | |
| G0008 | Administration of influenza virus vaccine | 130 | 76 | $0.00 |
| 90674 | 99 | 61 | $0.00 | |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 50 | 13 | $0.00 |
| 0064A | 20 | 12 | $0.00 |